Europe Mass Spectrometry Market Size & Outlook, 2026-2033
The mass spectrometry market in Europe is expected to reach a projected revenue of US$ 3,172.1 million by 2033. A compound annual growth rate of 6.7% is expected of Europe mass spectrometry market from 2026 to 2033.
In terms of revenue, Europe region accounted for 25.6% of the global mass spectrometry market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 3,598.3 million by 2033.
Europe mass spectrometry market is expected to experience lucrative growth over the forecast period. This growth can be attributed to the strong presence of pharmaceutical, biopharmaceutical, and biotechnology companies, coupled with the robust healthcare infrastructure and increased R&D spending in drug discovery & development.
In addition, the growing adoption of personalized medicine and advancements in disease diagnostics further propel market growth. Moreover, the market experiences growth due to the presence of key market players such as Bruker; Danaher Corporation; Thermo Fisher Scientific Inc.; Agilent Technologies, Inc.; Shimadzu Corporation; and others.
In addition, companies are launching new mass spectrometry devices and consumables, thereby leveraging their market presence. For instance, in August 2023, Thermo Fisher Scientific, Inc. launched the EXENT solution, an IVDR-certified mass spectrometry solution, in Belgium, France, Germany, Italy, the Netherlands, Spain, and the UK. This solution can be used for the detection and monitoring of monoclonal antibodies.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Mass Spectrometry Market Outlook will help companies and investors design strategic landscapes.
Quadrupole Liquid Chromatography-Mass Spectrometry was the largest segment with a revenue share of 40.55% in 2025.
Horizon Databook has segmented the Europe mass spectrometry market based on magnetic sector mass spectrometry, quadrupole liquid chromatography-mass spectrometry, gas chromatography-mass spectrometry (gc-ms), fourier transform-mass spectrometry (ft-ms), time-of-flight mass spectrometry (tofms), matrix assisted laser desorption/ionization-time-of-flight mass spectrometry (maldi-tof) covering the revenue growth of each sub-segment from 2021 to 2033.
Europe mass spectrometry market is expected to experience lucrative growth over the forecast period. This growth can be attributed to the strong presence of pharmaceutical, biopharmaceutical, and biotechnology companies, coupled with the robust healthcare infrastructure and increased R&D spending in drug discovery & development.
In addition, the growing adoption of personalized medicine and advancements in disease diagnostics further propel market growth. Moreover, the market experiences growth due to the presence of key market players such as Bruker; Danaher Corporation; Thermo Fisher Scientific Inc.; Agilent Technologies, Inc.; Shimadzu Corporation; and others.
In addition, companies are launching new mass spectrometry devices and consumables, thereby leveraging their market presence. For instance, in August 2023, Thermo Fisher Scientific, Inc. launched the EXENT solution, an IVDR-certified mass spectrometry solution, in Belgium, France, Germany, Italy, the Netherlands, Spain, and the UK. This solution can be used for the detection and monitoring of monoclonal antibodies.
Europe Mass Spectrometry Market Technology Outlook (Revenue, USD Million , 2021-2033)
Matrix Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF)
Europe Mass Spectrometry Market End Use Outlook (Revenue, USD Million , 2021-2033)
Pharmaceutical & Biotechnology Companies
Others
Government & Academic Institutions
Europe Mass Spectrometry Market Product Outlook (Revenue, USD Million , 2021-2033)
Consumables & Services
Instruments
Europe Mass Spectrometry Market Application Outlook (Revenue, USD Million , 2021-2033)
Metabolomics
Glycomics
Proteomics
Others
Reasons to subscribe to Mass Spectrometry Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mass Spectrometry Market Outlook databook
Our clientele includes a mix of Mass Spectrometry Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Mass Spectrometry Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Mass Spectrometry Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.